成人急性髓系白血病强化化疗幸存者三年内生活质量与身体功能的长期恢复
本研究在基线和3年内11个时间点评估急性髓系白血病(AML)强化化疗(IC)幸存者的生活质量、疲劳和3项身体功能指标,并与常模比较。3年时多数患者生活质量与疲劳恢复,但6分钟步行试验和握力恢复比例较低。
要点
- 3年时总体生活质量恢复比例分别为1年79%、2年75%、3年86%。
- FACT疲劳恢复比例1年68%、3年77%。
- 3年时6分钟步行试验恢复仅17%,握力恢复42%。
核心结论
- 绝大多数AML强化化疗幸存者在3年内实现生活质量和疲劳恢复,但身体功能恢复仍不理想。
研究设计与样本
- 在基线和3年内11个时间点收集AML幸存者生活质量、疲劳和3项身体功能指标,并与常模数据比较。
主要发现
- 总体生活质量恢复比例1年79%、2年75%、3年86%。
- 3年时QLQ-C30恢复最好的子量表为身体功能和情绪功能。
- FACT疲劳恢复比例1年68%、3年77%。
- 3年时6分钟步行试验恢复比例仅17%,握力恢复比例42%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We previously described impairments in quality of life (QOL) and physical function among acute myeloid leukemia (AML) survivors between diagnosis and 1 year. The aim of the current study is to describe and compare to normative data QOL and physical function recovery over 3 years from diagnosis and treatment with intensive chemotherapy (IC). At assessments done at baseline (pre-IC) and at 11 time points over 3 years, QOL, fatigue, and 3 physical performance measures (PPMs; grip strength, 6-min walk test (6MWT), and timed chair stands) were collected. Long-term recovery was defined by reaching scores within the minimum clinically important difference of normative data. Global QOL recovery was seen in 79% at 1 year, 75% at 2 years, and 86% at 3 years. At 3 years, the QLQ-C30 subscales with the greatest recovery were physical and emotional functioning. For FACT-fatigue, recovery was seen in 68% at 1 year and 77% at 3 years. Recovery on PPMs was poorer on average, with only 17% on the 6MWT and 42% in grip strength returning to normal at 3 years. The vast majority of AML survivors after IC achieve recovery in QOL and fatigue by three years. However, recovery in physical performance remained blunted.
引用
- Timilshina N, Breunis H, Tomlinson GA, et al. Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy. Leukemia. 2018. PMID: 29884902. doi:10.1038/s41375-018-0162-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。